Scott M. Langevin
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies 18
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 9
- Periodontics top 2%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 17
- Extracellular vesicles in disease 12
- RNA modifications and cancer 7
- Oncology top 10%
-
- Data Visualization and Analytics 7
-
- Genetic Syndromes and Imprinting 4
- Co-authors
- Karl T. KelseyEmanuela TaioliJennifer R. GrandisCarmen J. MarsitMichael D. McCleanMelissa EliotBrock C. ChristensenE. Andrés Houseman
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Scott M. Langevin
67 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 150
- Otorhinolaryngology 492
- Cancer Research 612
- Periodontics 124
- Molecular Biology 1.2k
- Oncology 342
Countries citing papers authored by Scott M. Langevin
This map shows the geographic impact of Scott M. Langevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Langevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Langevin more than expected).
Fields of papers citing papers by Scott M. Langevin
This network shows the impact of papers produced by Scott M. Langevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Langevin. The network helps show where Scott M. Langevin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott M. Langevin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 11 | |
| 6 | 2020 | 15 | |
| 7 | 2019 | 8 | |
| 8 | 2018 | 30 | |
| 9 | 2015 | 7 | |
| 10 | 2014 | 27 | |
| 11 | 2014 | 121 | |
| 12 | 2013 | 49 | |
| 13 | 2012 | 88 | |
| 14 | 2012 | 71 | |
| 15 | 2011 | 39 | |
| 16 | 2011 | 155 | |
| 17 | 2010 | 2 | |
| 18 | 2010 | 89 | |
| 19 | 2009 | 52 | |
| 20 | 2009 | 200 |
About Scott M. Langevin
Scott M. Langevin is a scholar working on Otorhinolaryngology, Cancer Research and Periodontics, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (18 papers), Epigenetics and DNA Methylation (17 papers), Cancer-related molecular mechanisms research (12 papers), Extracellular vesicles in disease (12 papers), MicroRNA in disease regulation (9 papers), Data Visualization and Analytics (7 papers), RNA modifications and cancer (7 papers) and Genetic Syndromes and Imprinting (4 papers). The work is most often cited by research in Otorhinolaryngology (492 citations), Cancer Research (612 citations) and Periodontics (124 citations). Scott M. Langevin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Karl T. Kelsey, Emanuela Taioli, Jennifer R. Grandis, Carmen J. Marsit, Michael D. McClean, Melissa Eliot, Brock C. Christensen, E. Andrés Houseman, Dominique S. Michaud and Heather H. Nelson. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.